Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease
about
New insights into the dichotomous role of innate cytokines in gut homeostasis and inflammationSAMP1/YitFc mouse strain: a spontaneous model of Crohn's disease-like ileitis.Unique gene expression and MR T2 relaxometry patterns define chronic murine dextran sodium sulphate colitis as a model for connective tissue changes in human Crohn's diseaseInflammatory bowel disease: clinical aspects and treatments.Medical therapy of stricturing Crohn's disease: what the gut can learn from other organs - a systematic review.Distinct profiles of effector cytokines mark the different phases of Crohn's diseaseThe microaerophilic microbiota of de-novo paediatric inflammatory bowel disease: the BISCUIT study.The gut microbiome in intestinal fibrosis: environmental protector or provocateur?STAT6 activation in ulcerative colitis: a new target for prevention of IL-13-induced colon epithelial cell dysfunctionSHIP-deficient mice develop spontaneous intestinal inflammation and arginase-dependent fibrosis.Biologics in paediatric Crohn's disease.Potential role of a navigator gene NAV3 in colorectal cancer.Crucial steps in the natural history of inflammatory bowel disease.IL12p40 regulates functional development of human CD4+ T cells: enlightenment by the elevated expressions of IL12p40 in patients with inflammatory bowel diseasesUp-regulation and pre-activation of TRAF3 and TRAF5 in inflammatory bowel disease.Crohn's disease complicated by strictures: a systematic review.Measurement of IL-12 (p40, p35), IL-23p19, and IFN-γ mRNA in duodenal biopsies of cats with inflammatory enteropathy.Long-term natural history of Crohn's diseaseJAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokinesIntestinal cytokine mRNA expression in canine inflammatory bowel disease: a meta-analysis with critical appraisal.Are we giving biologics too much time? When should we stop treatment?Natural history and long-term clinical course of Crohn's disease.Top-down therapy for Crohn's disease: rationale and evidence.Genetics of childhood-onset inflammatory bowel disease.New pathogenic paradigms in inflammatory bowel disease.Antitumor necrosis factor treatment for pediatric inflammatory bowel disease.Optimal use and cost-effectiveness of biologic therapies in inflammatory bowel disease.Cytokine blockade in inflammatory bowel diseases.Epidemiology of the transition from early to late Crohn's disease.Changes of the cytokine profile in inflammatory bowel diseases.Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion process.Circulating antibodies against bacterial wall products: are there arguments for early immunosuppression?Clinical progress in the two years following a course of exclusive enteral nutrition in 109 paediatric patients with Crohn's disease.Differences between adults and children: genetics and beyond.Cytokines and mucosal immunity.Review article: moving towards common therapeutic goals in Crohn's disease and rheumatoid arthritis.An Overview of the Innate and Adaptive Immune System in Inflammatory Bowel Disease.Stromal and immune cells in gut fibrosis: the myofibroblast and the scarface.The future developments in inflammatory bowel disease care.Impact of early thiopurines on surgery in 2770 children and young people diagnosed with inflammatory bowel disease: a national population-based study.
P2860
Q26823773-424FEC69-E8BA-47EB-BA9B-4C6B9874DD80Q30423660-84896FBB-791A-479D-8562-25FB04EC6C9FQ30657855-AA4A0563-E08B-48FE-BE48-7126852F4EDAQ34431476-9B0145BC-9202-433A-BE76-484E536B7757Q34504710-F75BFB93-884A-4C8C-8A5F-8F5E6A0C4BE9Q34563301-90B66C2B-CB89-4314-8DE2-B1481D96C99BQ34648376-870A74FA-AE32-44AE-B285-0ECA9CB84BE4Q34778411-394F6790-FA39-4114-A1EA-5D5D08A4C81BQ35061825-E84A7425-DC60-41A4-944B-2733C595B05AQ35070179-76A68E37-A6D1-4C41-94B4-1D9F52C2877BQ35579308-97661537-DF1D-4460-A573-506D8967E5C0Q35739529-751AC1AB-EEE9-4FD7-A233-4B6CEC072B2BQ36144457-9D463075-6AFC-4359-ACBE-E2A2FDFF280AQ36151081-97E8B294-725B-418E-A503-7077E89979D5Q36540116-4A0513A2-A161-4E7F-83C7-6B11622E11DAQ36945422-7A31CFC3-0271-4354-AA66-3F12E6FE691DQ36975275-3BB62325-A67B-44AC-A095-ED33F531BE9DQ37135931-5F721097-ACA5-40F3-B7FF-94C2F416E260Q37148745-DD12BF09-5583-46E9-A24E-BA37718CD7DBQ37243818-32E19ADC-9E39-4719-95C3-7460B26E3C45Q37276975-4BE125EE-671A-4344-A8D0-FFCFC758EC94Q37454530-F641C3C8-F9D5-46C5-A731-E628FEBECBE3Q37681484-A7D96144-AA43-47F1-9F96-8D1A937E206FQ37788639-F5CE873C-222C-45B2-BD83-D49CA08E6F4DQ37871532-FBB1FB7F-3954-4203-AB61-D7BC092C2674Q37936394-E6A25E1B-4AD4-4EAB-B7D5-77E291EC5926Q37947158-3262462B-CB82-44E7-A542-9F8AC118A6E7Q37952792-E1520AA5-8AA4-4207-A57C-7A8C872D9754Q38026397-1296B542-46F3-417C-B497-07A5D428ECA1Q38058782-4458AE94-AF1E-4DCD-BBBB-0B52D6B5479DQ38065036-76A53F4E-7816-4D9E-AD74-D9FB1F98953DQ38072225-DADEEAFC-09A0-43C4-BC4D-3C04747F1A01Q38077542-D8938976-8F30-4EEF-B055-F4AF21895397Q38241013-24382E36-B869-4679-B319-102A4DF1DDA9Q38247384-E81D6E65-BAB6-46B8-980A-F54F49460843Q38752119-7375968F-E245-4267-9394-56D38B24BBB0Q38990222-AE7216EB-8BA4-4F90-9452-54C7744CD9C2Q39401444-19090893-2300-430C-AA98-B4CCEF6604AAQ39594232-FD192C2A-25A7-4675-AAE1-B44AEF017E3FQ41485331-B780F2C5-B5DD-4921-963E-B7D9A8DB199B
P2860
Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease
@ast
Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease
@en
type
label
Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease
@ast
Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease
@en
prefLabel
Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease
@ast
Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease
@en
P2093
P2860
P356
P1433
P1476
Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease
@en
P2093
A D Levine
D G Binion
L J Saubermann
R S Blumberg
S Kugathasan
P2860
P304
P356
10.1136/GUT.2006.116467
P407
P577
2007-08-06T00:00:00Z